COVID-19: A Global Threat to the Nervous System
Ann Neurol 88:1-11, Koralnik, I.J. & Tyler, K.L., 2020
Childhood Multisystem Inflammatory Syndrome
NEJM 383:393-395, Levin, M., 2020
Neurologic Manifestations of Long COVID Differ Based on Acute COVID-19 Severity
Ann Neurol 94:146-159, Giraldo,G.S.P.,et al, 2023
Multisystem Involvement in Post-Acute Sequelae of Coronavirus Disease 19
Ann Neurol 91:367-379, Novak, P.,et al, 2022
Neurological Events Reported after COVID-19 Vaccines: An Analysis of Vaccine Adverse Event Reporting System
Ann Neurol 91:756-771, Frontera, J.A.,et al, 2022
Clinical Manifestation,Management,and Outcomes in Patients with COVID-19 Vaccine-Induced Acute Encephalitis:Two Case Reports and a Literature Review
Vaccines 10:1230, Shyu,S.,et al, 2022
Neurologic Involvement in Children and Adolescents Hospitalized in the United States for Covid-19 or Multisystem Inflammatory Syndrome
JAMA Neurol 78:536-547, LaRovere, K.L.,et al, 2021
Sudden and Complete Olfactory Loss Function as a Possible Symptom of COVID-19
JAMA Otolaryngology Head Neck Surg doi:10.1001/JAMAOTO.2020.0832, Elieyer, M.,et al, 2020
Neurologic Complications of Coronavirus Infections
Neurol 94:809-810, Nath, A., 2020
Olfactory Dysfunction in COVID-19
JAMA doi:10.1001/JAMA.2020.8391, Whitcroft, K.L. & Hummel, T., 2020
Neuropathological Features of Covid-19
NEJM doi:10.1056/NEJMc2019373, Solomon, I.H.,et al, 2020
A case of COVID-19-associated pharyngeal-cervical-brachial variant of Guillain-Barre syndrome
Neurol 95:978-983, Liberatore, G.,et al, 2020
Guillain-Barre Syndrome Associated with SARS-CoV-2
NEJM 382:2574-2576, Tuscano, G.,et al, 2020
Covd-19-Associated Myopathy Caused by Type 1 Interferonopathy
NEJM 383:2389-2390, Manzano, A.C.,et al, 2020